We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$20.1B
AUM Growth
+$951M
Cap. Flow
-$224M
Cap. Flow %
-1.12%
Top 10 Hldgs %
32.44%
Holding
721
New
63
Increased
299
Reduced
261
Closed
36

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$55.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$46.1M
3
BABA icon
Alibaba
BABA
+$45M
4
NEE icon
NextEra Energy
NEE
+$40.9M
5
AMZN icon
Amazon
AMZN
+$38.3M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$50.3M
2
META icon
Meta Platforms (Facebook)
META
+$44.2M
3
PG icon
Procter & Gamble
PG
+$34.1M
4
ZTS icon
Zoetis
ZTS
+$33.6M
5
CAH icon
Cardinal Health
CAH
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 34.01%
2 Healthcare 26.73%
3 Financials 11.13%
4 Consumer Discretionary 7.93%
5 Communication Services 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALGM icon
476
Allegro MicroSystems
ALGM
$7.73B
$2.32M 0.01%
87,888
-1,287
-1% -$35.4K
ARES icon
477
Ares Management
ARES
$28.9B
$2.32M 0.01%
14,336
-4,219
-23% -$657K
DHI icon
478
D.R. Horton
DHI
$40B
$2.31M 0.01%
16,007
-2,766
-15% -$421K
L icon
479
Loews
L
$23.9B
$2.3M 0.01%
+21,827
New +$2.25M
XYZ
480
Block Inc
XYZ
$48.4B
$2.24M 0.01%
34,444
-2,288
-6% -$158K
KVUE icon
481
Kenvue
KVUE
$36.9B
$2.21M 0.01%
128,380
-18,474
-13% -$302K
LNN icon
482
Lindsay Corp
LNN
$1.13B
$2.18M 0.01%
18,512
-7,552
-29% -$909K
RF icon
483
Regions Financial
RF
$26.4B
$2.17M 0.01%
80,174
SPG icon
484
Simon Property Group
SPG
$74.4B
$2.16M 0.01%
11,694
-2,104
-15% -$382K
DOC icon
485
Healthpeak Properties
DOC
$15.1B
$2.15M 0.01%
133,865
+20,211
+18% +$356K
RKLB icon
486
Rocket Lab Corp
RKLB
$40.6B
$2.14M 0.01%
30,662
-2,377
-7% -$136K
SFM icon
487
Sprouts Farmers Market
SFM
$8.13B
$2.05M 0.01%
25,747
+3,899
+18% +$350K
STM icon
488
STMicroelectronics
STM
$46.7B
$1.99M 0.01%
76,811
-36,714
-32% -$942K
TYL icon
489
Tyler Technologies
TYL
$12.7B
$1.98M 0.01%
4,363
+1,145
+36% +$545K
WSM icon
490
Williams-Sonoma
WSM
$26.9B
$1.96M 0.01%
10,951
+1,093
+11% +$205K
VRSN icon
491
VeriSign
VRSN
$26.2B
$1.94M 0.01%
7,971
-23,849
-75% -$5.99M
CINF icon
492
Cincinnati Financial
CINF
$27.3B
$1.92M 0.01%
11,762
GEHC icon
493
GE HealthCare
GEHC
$30.7B
$1.92M 0.01%
23,388
+259
+1% +$20.2K
HPQ icon
494
HP
HPQ
$24.9B
$1.91M 0.01%
85,927
+16,819
+24% +$429K
HSY icon
495
Hershey
HSY
$35.2B
$1.88M 0.01%
10,314
-391
-4% -$71.5K
ADM icon
496
Archer Daniels Midland
ADM
$38.2B
$1.88M 0.01%
32,643
GDDY icon
497
GoDaddy
GDDY
$11B
$1.86M 0.01%
15,025
-26,325
-64% -$3.41M
ITRI icon
498
Itron
ITRI
$4.36B
$1.85M 0.01%
19,974
CNI icon
499
Canadian National Railway
CNI
$76.9B
$1.85M 0.01%
18,696
+3,538
+23% +$340K
EXR icon
500
Extra Space Storage
EXR
$31.3B
$1.85M 0.01%
14,195
+1,767
+14% +$241K

Similar funds

Candriam SCA's Q4 2025 Portfolio in Review

As of Q4 2025, Candriam SCA held 721 positions worth $20.1B, up 5% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q4 2025 filing shows 63 new, 299 increased, 261 reduced and 36 closed positions. Its largest new stake was Alibaba: 276,080 shares worth $40.5M. The largest sale was Equinix, an estimated $50.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2025 buy was Alibaba: 276,080 shares worth $40.5M.
  • Candriam SCA added most to AbbVie in Q4 2025, an estimated $55.1M increase.
  • Candriam SCA's biggest Q4 2025 reduction was Equinix, cutting an estimated $50.3M.
  • Candriam SCA fully exited Universal Display in Q4 2025, selling an estimated $27.1M.
  • Candriam SCA's ten largest holdings make up 32% of its $20.1B portfolio in Q4 2025.
  • Candriam SCA opened 63 new positions and closed 36 in Q4 2025.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $20.1B.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.